P232 Once-daily co-administration of glycopyrronium and indacaterol via Breezhaler® device improves lung function and symptoms in patients with COPD versus indacaterol alone: the GLOW6 study
P232 Once-daily co-administration of glycopyrronium and indacaterol via Breezhaler® device improves lung function and symptoms in patients with COPD versus indacaterol alone: the GLOW6 study